InsidersTradesSigma
Follow the 명문제약 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are quoted on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 명문제약 has recorded 3 reports. Market capitalisation: €42.6bn. The latest transaction was disclosed on 2 July 2026 (Other). Among the most active insiders: 임기섭. Every trade is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Myungmoon Pharmaceutical is a South Korean pharmaceutical company focused on the development and marketing of medications. It is listed on the XKRX market.